SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001479290-23-000032
Filing Date
2023-03-03
Accepted
2023-03-03 16:31:39
Documents
2
Period of Report
2023-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_167787903709898.html 3  
1 FORM 3 wf-form3_167787903709898.xml 3 1732
2 CORIC POA poacoricv2.htm EX-24 3622
  Complete submission text file 0001479290-23-000032.txt   6768
Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510
Business Address
Coric Vlad (Reporting) CIK: 0001704317 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36297 | Film No.: 23704649